MapLight Therapeutics, Inc Common Stock
Yahoo Finance • 12 hours ago
Nan Fung Group Sells $4.3 Million in Oculis Shares As Lead Drug Stumbles
What happened According to a recent SEC filing, Nan Fung Group Holdings Ltd reduced its position in Oculis(NASDAQ:OCS) by 163,957 shares during the first quarter of 2026. The estimated value of the trade was $4.3 million, based on the qua... Full story
Yahoo Finance • 9 days ago
Why This Fund Made a $66 Million Bet on Damora Therapeutics Amid a 700% Surge
FCPM III Services B.V. disclosed a new position in Damora Therapeutics(NASDAQ:DMRA) as of March 31, 2026, acquiring 2,441,000 shares for an estimated $65.63 million based on quarterly average pricing. What happened According to a Securit... Full story
Yahoo Finance • 9 days ago
Dyne Stock Is Up 56%. Here's What a $14 Million Stake Reduction Could Mean
On May 15, 2026, FCPM III Services B.V. reported a sale of 818,460 shares of Dyne Therapeutics(NASDAQ:DYN), an estimated $14.11 million trade based on quarterly average pricing. What happened According to a Securities and Exchange Commis... Full story
Yahoo Finance • last month
This MapLight Insider Sold 69,000 Shares for $2.1 Million at the End of April
MapLight Therapeutics(NASDAQ:MPLT) Chief Administrative and Accounting Officer Jonathan Gillis disclosed the direct sale of 69,835 shares of common stock in multiple open-market transactions on April 27 and April 28, 2026, according to an... Full story
Yahoo Finance • 2 months ago
What a 1% Insider Sale of MPLT Stock Signals Ahead of 2026 Trial Data
Key Points An MPLT executive reported selling 3,316 shares directly on April 15, 2026, for a transaction value of approximately $88,000 at an average price of $26.61 per share. No indirect or derivative shares were involved in the transac... Full story
Yahoo Finance • 2 months ago
MapLight Therapeutics (MPLT): The Best Healthcare Stock Insiders Are Buying
MapLight Therapeutics, Inc. (NASDAQ:MPLT) is one of the 8 Healthcare Stocks Insiders Are Buying. On April 8, 2026, Needham initiated coverage of MapLight Therapeutics, Inc. (NASDAQ:MPLT) with a Buy rating and a $37 price target. Needham s... Full story
Yahoo Finance • 6 months ago
MapLight Therapeutics to join Russell 3000, Russell 2000 and Russell Microcap indexes
* MapLight Therapeutics (NASDAQ:MPLT [https://seekingalpha.com/symbol/MPLT]) has been added to the Russell 2000 Index and the broader Russell 3000 Index, effective at the open of U.S. equity markets on December 22, 2025, as part of the 2... Full story